Andrew Z. Wang Laboratory of Nano- and Translational Medicine, Department of Radiation Oncology, Lineberger Comprehensive Cancer Center University of North Carolina School of Medicine Biography Publications Institution JoVE Articles Andrew Z. Wang has not added a biography. If you are Andrew Z. Wang and would like to personalize this page please email our Author Liaison for assistance. Publications Is Primary Prostate Cancer Treatment Influenced by Likelihood of Extraprostatic Disease? A Surveillance, Epidemiology and End Results Patterns of Care Study International Journal of Radiation Oncology, Biology, Physics. Jan, 2012 | Pubmed ID: 22300560 Preparation of Neutron-Activatable Holmium Nanoparticles for the Treatment of Ovarian Cancer Metastases Small (Weinheim an Der Bergstrasse, Germany). Feb, 2012 | Pubmed ID: 22298503 Nanoparticle Delivery of Cancer Drugs Annual Review of Medicine. Feb, 2012 | Pubmed ID: 21888516 Folate-targeted Polymeric Nanoparticle Formulation of Docetaxel is an Effective Molecularly Targeted Radiosensitizer with Efficacy Dependent on the Timing of Radiotherapy ACS Nano. Nov, 2011 | Pubmed ID: 22011071 Folate-targeted Nanoparticle Delivery of Chemo- and Radiotherapeutics for the Treatment of Ovarian Cancer Peritoneal Metastasis Biomaterials. Nov, 2011 | Pubmed ID: 21843904 Chemoradiation Therapy in the Management of Gastrointestinal Malignancies Future Oncology (London, England). Mar, 2011 | Pubmed ID: 21417904 Using Mechanobiological Mimicry of Red Blood Cells to Extend Circulation Times of Hydrogel Microparticles Proceedings of the National Academy of Sciences of the United States of America. Jan, 2011 | Pubmed ID: 21220299 ChemoRad Nanoparticles: a Novel Multifunctional Nanoparticle Platform for Targeted Delivery of Concurrent Chemoradiation Nanomedicine (London, England). Apr, 2010 | Pubmed ID: 20394530 Improving Local Control in Rectal Cancer: Radiation Sensitizers or Radiation Dose? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Apr, 2010 | Pubmed ID: 20194836 Self-assembled Lipid--polymer Hybrid Nanoparticles: a Robust Drug Delivery Platform ACS Nano. Aug, 2008 | Pubmed ID: 19206374 HER-2-targeted Nanoparticle-affibody Bioconjugates for Cancer Therapy ChemMedChem. Dec, 2008 | Pubmed ID: 19012296 Biofunctionalized Targeted Nanoparticles for Therapeutic Applications Expert Opinion on Biological Therapy. Aug, 2008 | Pubmed ID: 18613759 Superparamagnetic Iron Oxide Nanoparticle-aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy ChemMedChem. Sep, 2008 | Pubmed ID: 18613203 Nanotechnology and Aptamers: Applications in Drug Delivery Trends in Biotechnology. Aug, 2008 | Pubmed ID: 18571753 Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique Shrirang Karve1,2, Michael E. Werner1,2, Natalie D. Cummings1,2, Rohit Sukumar1,2, Edina C. Wang1,2, Ying-Ao Zhang1,2, Andrew Z. Wang1,2 1Laboratory of Nano- and Translational Medicine, Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, 2Carolina Center for Nanotechnology Excellence, University of North Carolina JoVE 3398 Bioengenharia
Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique Shrirang Karve1,2, Michael E. Werner1,2, Natalie D. Cummings1,2, Rohit Sukumar1,2, Edina C. Wang1,2, Ying-Ao Zhang1,2, Andrew Z. Wang1,2 1Laboratory of Nano- and Translational Medicine, Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, 2Carolina Center for Nanotechnology Excellence, University of North Carolina JoVE 3398 Bioengenharia